SCIDOT-16. T2-WEIGHTED IMAGING MAY BE INDICATIVE OF DRUG DISTRIBUTION IN GLIOBLASTOMA PATIENTS

OBJECTIVES: Dogma suggests that for brain tumors, regions of enhancement on T1-weighted gadolinium contrast enhanced (T1Gd) magnetic resonance imaging (MRI) correlate with intravenously delivered drug distribution as enhancement indicates a compromised blood-brain barrier (BBB). However, poor respon...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Neuro Oncol
Autors principals: Jackson, Pamela, Kim, Minjee, Hawkins-Daarud, Andrea, Singleton, Kyle, Mohammad, Afroz, Burns, Terence, Parney, Ian, Hu, Leland, Kaufmann, Timothy, Elmquist, William, Sarkaria, Jann, Swanson, Kristin
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2019
Matèries:
Abstracts from the 3rd Sno-Scidot Joint Conference on Therapeutic Delivery to the CNS
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6846504/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz175.1152
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars